Vericel Corp (VCEL)
46.11
-0.31
(-0.67%)
USD |
NASDAQ |
Apr 24, 16:00
46.09
-0.02
(-0.04%)
After-Hours: 20:00
Vericel Total Assets (Quarterly): 353.66M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 353.66M |
| September 30, 2023 | 318.12M |
| June 30, 2023 | 310.71M |
| March 31, 2023 | 265.10M |
| December 31, 2022 | 273.00M |
| September 30, 2022 | 248.02M |
| June 30, 2022 | 244.82M |
| March 31, 2022 | 240.29M |
| December 31, 2021 | 243.70M |
| September 30, 2021 | 224.14M |
| June 30, 2021 | 221.94M |
| March 31, 2021 | 211.46M |
| December 31, 2020 | 205.61M |
| September 30, 2020 | 157.50M |
| June 30, 2020 | 146.69M |
| March 31, 2020 | 150.26M |
| December 31, 2019 | 153.24M |
| September 30, 2019 | 137.53M |
| June 30, 2019 | 125.83M |
| March 31, 2019 | 141.23M |
| December 31, 2018 | 118.69M |
| September 30, 2018 | 124.46M |
| June 30, 2018 | 122.19M |
| March 31, 2018 | 52.41M |
| December 31, 2017 | 54.58M |
| Date | Value |
|---|---|
| September 30, 2017 | 40.28M |
| June 30, 2017 | 36.53M |
| March 31, 2017 | 40.59M |
| December 31, 2016 | 48.60M |
| September 30, 2016 | 28.02M |
| June 30, 2016 | 29.43M |
| March 31, 2016 | 33.06M |
| December 31, 2015 | 34.31M |
| September 30, 2015 | 35.82M |
| June 30, 2015 | 41.22M |
| March 31, 2015 | 44.49M |
| December 31, 2014 | 47.58M |
| September 30, 2014 | 50.38M |
| June 30, 2014 | 19.84M |
| March 31, 2014 | 9.878M |
| December 31, 2013 | 9.215M |
| September 30, 2013 | 12.20M |
| June 30, 2013 | 5.683M |
| March 31, 2013 | 10.58M |
| December 31, 2012 | 15.18M |
| September 30, 2012 | 22.71M |
| June 30, 2012 | 30.44M |
| March 31, 2012 | 38.66M |
| December 31, 2011 | 7.739M |
| September 30, 2011 | 14.07M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
125.83M
Minimum
Jun 2019
353.66M
Maximum
Dec 2023
222.72M
Average
224.14M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Arbutus Biopharma Corp | 144.40M |
| Chimerix Inc | 212.77M |
| Karyopharm Therapeutics Inc | 240.44M |
| Axsome Therapeutics Inc | 588.24M |
| Y-mAbs Therapeutics Inc | 127.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 127.70M |
| Shareholders Equity (Quarterly) | 225.95M |
| Current Ratio | 4.495 |